Akebia Therapeutics has initiated clinical development of a new investigational therapy aimed at preventing or treating acute kidney injury (AKI) associated with cardiac surgery. The
Triple negative breast cancer, the most aggressive form of breast cancer, is under attack. Adelaide University researchers, led by Dr. Theresa Hinkey, report that unlike
CatalYm has initiated patient enrollment in the GDFATHER-HCC-01 trial, a Phase 2b study investigating visugromab as part of a combinatorial treatment strategy for patients with
Phase 2 data suggest meaningful skin improvement and an acceptable safety profile As reported on Healio, litifilimab, an investigational therapy developed by Biogen, demonstrated encouraging
As reported on Inside Precision Medicine, Researchers at Stanford have created a new urine test that helps doctors understand how well bladder cancer treatments are
Chugai Pharmaceutical Co., Ltd. announced that Roche has made the strategic decision to discontinue clinical development of GYM329 (emugrobart), an investigational anti-latent myostatin antibody, for
As reported on PharmaBiz, Amgen has announced encouraging topline results from a phase 3 clinical trial evaluating a subcutaneous formulation of Tepezza (teprotumumab-trbw) for adults
Most of us have heard of the fight-or-flight stress response. It becomes activated when we believe there is a chance we can outfight or outrun
Telomir Pharmaceuticals has taken a significant step forward in the development of a novel therapeutic agent for one of oncology’s most challenging cancers. As reported
I have battled several autoimmune and neurological conditions that are triggered by food and other factors for over 50 years. It took most of my
The traditional model of HIV care has long centered on one fundamental requirement: patients must take medication every single day, without fail. Yet this model
As reported by GlobeNewsWire, results from the Phase 3 VALOR trial evaluating brepocitinib in adults with dermatomyositis have been published in the New England Journal
Editor’s Note: Patient Worthy is pleased to share the final part in a series of excerpts by Dana Langston. Chapter 36: Holding the Line Knowing
For patients living with primary biliary cholangitis (PBC), a rare autoimmune liver disease, an often-overlooked symptom has plagued their existence, an intense, maddening internal itch
As reported on PharmaBiz, a novel treatment strategy combining dual immunotherapy, targeted therapy, and transarterial chemoembolization (TACE) has demonstrated meaningful clinical benefit for patients with
Editor’s Note: Patient Worthy is pleased to share part 4 of 5 in a series of excerpts written by Dana Langston. Part 7: Legacy &
When standard depression medications fail, patients face a devastating reality. Approximately one-third of people with major depressive disorder do not adequately respond to conventional antidepressants,
As reported on BioPharmaDive, Amgen has announced positive Phase 3 results for a subcutaneous version of its thyroid eye disease (TED) therapy Tepezza, suggesting the
💙 Testing & Diagnosis in Parkinson’s Disease 💙
Receiving a Parkinson’s diagnosis is not just a medical moment, it’s a deeply personal one. There is no single test for Parkinson’s. Instead, doctors take time to listen, observe symptoms, and understand how each person is feeling and moving. Imaging and other tests are sometimes used, not to rush answers, but to gently rule out other causes and bring greater clarity. This process often happens over time, with care, patience, and follow‑up. If you or a loved one are going through testing, know that questions are welcome, support is always available, and you don’t have to walk this path alone. 💛
#ParkinsonsDisease #PDawareness #PatientWorthy #ShareYourStory #YouAreNotAlone
Many people describe a moment when they look back at everything they’ve navigated and realize they’ve been stronger than they ever expected.
Living with ongoing health challenges often requires resilience in ways that aren’t always visible to others. Recognizing that strength can be a meaningful moment in someone’s journey.
If you’re comfortable sharing, have you ever had a moment where you realized you were stronger than you thought?
#RareDisease #RareDiseaseAwareness #ChronicIllness #ChronicIllnessAwareness #PatientWorthy
Fact Friday: Learn about hypoxic-ischemic encephalopathy this #HIEawarenessmonth - what it is, how common it is, and why early intervention matters. #HIE #HIEawarenessmonth #NeonatalCare #hypoxicischemicencephalopathy
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
